Fundraising Fox
Ankyra Therapeutics
Austin, US · Founded 2019 · Delaware corporation · 25 employees on LinkedIn · 7 known investors
Find your way into Ankyra Therapeutics
Sign up to see every warm intro you have to Ankyra Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ankyra Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.
Founders & leadership
Ankyra Therapeutics was founded in 2019 by Tillman Gerngross.
Board
Investors · 7
How we know: GV (Google Ventures)'s portfolio page · ankyratx.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: ankyratx.com · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · ankyratx.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$59.5M disclosed across 2 of 3 rounds · 2020–2024
- Undisclosed amountSeries BOct 2024
Borealis Ventures, Fidelity Management & Research Company LLC, GV, Mithril Capital, Polaris Partners, Sands Capital Ventures, Spring Mountain Capital
Source ↗
▶$45MraisedSep 2021 · 14 investors · BiotechnologyRule 506(b)
- Ajay RoyanDirector
- Terrance McGuireDirector
- Tillman GerngrossExecutive Officer, Director
- Philip FerneauDirector
- Offering amount
- $45M
- Amount sold
- $45M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$14.5MraisedMay 2020 · 4 investors · Other Health CareRule 506(b)
- Terrance McGuireDirector
- Tillman GerngrossExecutive Officer, Director
- Offering amount
- $14.5M
- Amount sold
- $14.5M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Ankyra Therapeutics.
In the news
Frequently asked questions
- What does Ankyra Therapeutics do?
- Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.
- Who founded Ankyra Therapeutics?
- Ankyra Therapeutics was founded by Tillman Gerngross in 2019.
- Who are Ankyra Therapeutics's investors?
- Ankyra Therapeutics's investors include GV (Google Ventures), Fidelity Investments, Mithril Capital Management, Polaris Partners, Sands Capital Ventures, Spring Mountain Capital.
- How much funding has Ankyra Therapeutics raised?
- Ankyra Therapeutics has disclosed $59.5M raised across 2 of its 3 known rounds.
- Where is Ankyra Therapeutics headquartered?
- Ankyra Therapeutics is headquartered in Austin, US.